share_log

中金:合成生物学有望引领医药制造的未来

CICC: Synthetic biology is expected to lead the future of pharmaceutical manufacturing

Sina Finance ·  Sep 19, 2022 08:32
According to CICC's research report, synthetic biology is a breakthrough production technology that can reduce reliance on non-renewable energy sources such as oil and coal, solve the problems of high energy consumption and high pollution in chemical engineering, and drastically reduce production costs. Healthcare is an important application field of synthetic biology. Currently, there is a complete layout in the upper middle and upper reaches. Application fields include drug synthesis, disease diagnosis, and medical aesthetics. With breakthroughs in enabling technologies such as gene sequencing and gene editing and synthesis, synthetic biology ushered in a window of time for accelerated development, bringing breakthrough innovation to traditional pharmaceutical manufacturing, which is expected to lead the future of pharmaceutical manufacturing. CB Insights predicts that the market size of synthetic biology in the healthcare field will reach 5 billion US dollars by 2024, with great market potential.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment